Cardiac Magnetic Resonance in Pulmonary Hypertension—an Update
Authors:
Open Access
- 7 November 2020
- journal article
- review article
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 13 (12) , 1-9
Abstract
Purpose of Review: This article reviews advances over the past 3 years in cardiac magnetic resonance (CMR) imaging in pulmonary hypertension (PH). We aim to bring the reader up-to-date with CMR applications in diagnosis, prognosis, 4D flow, strain analysis, T1 mapping, machine learning and ongoing research. Recent Findings: CMR volumetric and functional metrics are now established as valuable prognostic markers in PH. This imaging modality is increasingly used to assess treatment response and improves risk stratification when incorporated into PH risk scores. Emerging techniques such as myocardial T1 mapping may play a role in the follow-up of selected patients. Myocardial strain may be used as an early marker for right and left ventricular dysfunction and a predictor for mortality. Machine learning has offered a glimpse into future possibilities. Ongoing research of new PH therapies is increasingly using CMR as a clinical endpoint. Summary: The last 3 years have seen several large studies establishing CMR as a valuable diagnostic and prognostic tool in patients with PH, with CMR increasingly considered as an endpoint in clinical trials of PH therapies. Machine learning approaches to improve automation and accuracy of CMR metrics and identify imaging features of PH is an area of active research interest with promising clinical utility.Keywords
Funding Information
- Wellcome Trust (215799/Z/19/Z, 205188/Z/16/Z)
This publication has 99 references indexed in Scilit:
- Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: Results from two institutionsMagnetic Resonance in Medicine, 2014
- Evaluation of Elevated Mean Pulmonary Arterial Pressure Based on Magnetic Resonance 4D Velocity Mapping: Comparison of Visualization TechniquesPLOS ONE, 2013
- Changes in Large Pulmonary Arterial Viscoelasticity in Chronic Pulmonary HypertensionPLOS ONE, 2013
- Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated CardiomyopathyJAMA, 2013
- Human non-contrast T1 values and correlation with histology in diffuse fibrosisHeart, 2013
- Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and IrelandAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertensionJournal of Cardiovascular Magnetic Resonance, 2012
- Magnetic Resonance–Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial PressureCirculation: Cardiovascular Imaging, 2008
- Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedsideEuropean Radiology, 2006
- Human Myocardium: Single-Breath-hold MR T1 Mapping with High Spatial Resolution—Reproducibility StudyRadiology, 2006